US Stock Insider Trading | Oluz Medical disclosed 10 insider transactions on February 5

K-LinePoet · 2026-02-28T09:30:48+00:00

On February 5, 2026, OlorzMei Medical's director Torley Helen disclosed multiple insider transactions, including sales and purchases. She bought 50,000 shares on the same day, totaling $603,500. The company focuses on biopharmaceuticals and innovative product development.

K-LinePoet

2026-02-28 09:30:48

Abstract generation in progress

On February 5, 2026, Halozyme Therapeutics (HALO) disclosed 10 insider trading transactions. Director Torley Helen purchased 20,000 shares on the same day.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 5, 2026	Director	Torley Helen	February 5, 2026	Sell	5,376	78.38	$421,400
February 5, 2026	Director	Torley Helen	February 5, 2026	Sell	4,624	78.94	$365,000
February 3, 2026	Director	Torley Helen	February 3, 2026	Sell	7,790	76.73	$597,800
February 3, 2026	Director	Torley Helen	February 3, 2026	Sell	9,659	75.94	$733,500
February 4, 2026	Director	Torley Helen	February 4, 2026	Sell	10,100	77.54	$783,200
February 4, 2026	Director	Torley Helen	February 4, 2026	Sell	9,900	76.94	$761,700
February 3, 2026	Director	Torley Helen	February 3, 2026	Sell	2,551	74.88	$191,000
February 5, 2026	Director	Torley Helen	February 5, 2026	Buy	50,000	12.07	$603,500
January 5, 2026	Director	Bernadette Connaughton	January 5, 2026	Sell	2,000	70.25	$140,500
January 3, 2026	Executive	Mark Howard Snyder	January 3, 2026	Sell	4,243	70.31	$298,300

【Company Information】

Halozyme Therapeutics, Inc. is a biopharmaceutical company founded in 1998. In November 2007, the company restructured and registered in Delaware (previously registered in Nevada). The company focuses on the development and commercialization of innovative products. It researches extracellular matrix and extracellular regions, including cell migration, signaling, and survival. Over the years, the company has developed unique scientific expertise that allows it to pursue environment-focused therapeutic approaches.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.